fda warning letters compounded tirzepatide 2024 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Why the FDA Issued 30
Description
Hilda E
While obesity is increasingly recognised as a chronic condition, regulatory and reimbursement policies have struggled to keep up
These symptoms can feel identical to a panic attack
While Mounjaro and Zepbound contain the same active ingredient, tirzepatide, they are approved for different purposes
